Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Altimmune Inc. (ALT)

11.19   1.26 (12.69%) 07-07 16:00
Open: 9.92 Pre. Close: 9.93
High: 11.38 Low: 9.86
Volume: 2,484,161 Market Cap: 242M
Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company develops HepTcell, an immunotherapeutic product candidate that has completed Phase I clinical trial for patients chronically infected with the hepatitis B virus; NasoShield, an anthrax vaccine to provide for protection after a single intranasal administration; NasoVAX, a recombinant intranasal vaccine product candidate; and AdCOVID, a single-dose intranasal vaccine to protect against COVID-19 Its preclinical stage products include ALT-801, a novel peptide-based dual GLP-1/Glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis; and ALT-702, an investigational tumor immunostimulant for treating cancer. The company also develops veterinary product candidates. It has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. Altimmune, Inc.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.391 - 11.446 11.446 - 11.493
Low: 9.743 - 9.799 9.799 - 9.848
Close: 11.095 - 11.193 11.193 - 11.278

Technical analysis

as of: 2020-07-07 4:31:30 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 14.88     One year: 17.38
Support: Support1: 8.40    Support2: 5.71
Resistance: Resistance1: 12.74    Resistance2: 14.88
Pivot: 9.15
Moving Average: MA(5): 10.44     MA(20): 8.60
MA(100): 4.77     MA(250): 3.09
MACD: MACD(12,26): 1.11     Signal(9): 0.98
Stochastic oscillator: %K(14,3): 62.00     %D(3): 61.10
RSI: RSI(14): 69.91
52-week: High: 12.74  Low: 1.51  Change(%): 356.7
Average Vol(K): 3-Month: 296091  10-Days: 273631

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ALT has closed below upper band by 11.7%. Bollinger Bands are 125.1% wider than normal. The large width of the bands suggest high volatility as compared to ALT's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

Wed, 08 Jul 2020
What Type Of Shareholders Make Up Altimmune, Inc.'s (NASDAQ:ALT) Share Registry? - Yahoo Finance

Wed, 08 Jul 2020
Better Coronavirus Stock: Altimmune vs. Vaxart - Motley Fool

Tue, 07 Jul 2020
Altimmune, Inc. (ALT)’s -4.7% Retreat Makes It Worth Considering Again - Stocks Register

Thu, 02 Jul 2020
What's Behind Altimmune, Inc. (ALT) Volatile Ride? - The News Heater

Tue, 30 Jun 2020
Momentum investing with Altimmune Inc (NMQ:ALT) - Yahoo Finance UK

Mon, 29 Jun 2020
Can Altimmune Inc (ALT) Stock Rise to the Top of Healthcare Sector? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 20
Shares Float (M) 10
% Held by Insiders 17.11
% Held by Institutions 8.38
Shares Short (K) 2,640
Shares Short P. Month (K) 1,860

Stock Financials

EPS -1.530
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.770
Profit Margin
Operating Margin -454.94
Return on Assets (ttm) -24.0
Return on Equity (ttm) -44.1
Qtrly Rev. Growth -25.1
Gross Profit (p.s.) -0.561
Sales Per Share 0.252
EBITDA (p.s.) -1.129
Qtrly Earnings Growth
Operating Cash Flow (M) -12
Levered Free Cash Flow (M) -12

Stock Valuations

PE Ratio -7.31
PEG Ratio
Price to Book value 4.04
Price to Sales 44.47
Price to Cash Flow -19.01

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date 2017-02-02
Ex-Dividend Date 2017-01-19
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.